Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
DDOG
|
Alexis Le Quoc
Chief Technology Officer |
SELL
Open market or private sale
|
Indirect | 77,513 Reduced 48.11% |
$8,148,941
$105.13 p/Share
|
Feb 02
2021 |
|
IBKR
|
Paul Jonathan Brody
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 12,699 Reduced 7.66% |
$866,580
$68.24 p/Share
|
Feb 02
2021 |
|
MORN
|
Joseph D Mansueto
Executive Chairman |
SELL
Open market or private sale
|
Direct | 12,921 Reduced 0.07% |
$3,128,303
$242.11 p/Share
|
Feb 02
2021 |
|
CBSH
|
Patricia R Kellerhals
Senior Vice President |
SELL
Open market or private sale
|
Direct | 524 Reduced 6.93% |
$35,973
$68.65 p/Share
|
Feb 02
2021 |
|
CBSH
|
David W Kemper
Executive Chairman |
SELL
Open market or private sale
|
Direct | 17,980 Reduced 1.54% |
$1,224,438
$68.1 p/Share
|
Feb 02
2021 |
|
W
|
Thomas Netzer
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 743 Reduced 3.73% |
$210,039
$282.69 p/Share
|
Feb 02
2021 |
|
W
|
James R. Miller
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 4,067 Reduced 11.38% |
$1,149,090
$282.54 p/Share
|
Feb 02
2021 |
|
GH
|
Amir Ali Talasaz
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 130,893 Reduced 4.75% |
$20,648,371
$157.75 p/Share
|
Feb 02
2021 |
|
GH
|
Amir Ali Talasaz
Co-Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 19,498 Reduced 0.65% |
$3,075,810
$157.75 p/Share
|
Feb 02
2021 |
|
UMBF
|
J Mariner Kemper
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.05% |
$7,302
$73.02 p/Share
|
Feb 02
2021 |
|
PTCT
|
Christine Marie Utter
SVP, CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 652 Reduced 3.8% |
$37,581
$57.64 p/Share
|
Feb 02
2021 |
|
PGNY
|
David J Schlanger
Executive Chairman |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 100.0% |
$2,424,500
$48.49 p/Share
|
Feb 02
2021 |
|
PGNY
|
Peter Anevski
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Indirect | 21,000 Reduced 3.1% |
$1,019,970
$48.57 p/Share
|
Feb 02
2021 |
|
RMBS
|
Luc Seraphin
President and CEO |
SELL
Open market or private sale
|
Direct | 36,366 Reduced 13.18% |
$703,318
$19.34 p/Share
|
Feb 02
2021 |
|
SSTK
|
Jonathan Oringer
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 14,633 Reduced 0.11% |
$985,240
$67.33 p/Share
|
Feb 02
2021 |
|
NOVA
|
Kris W Hillstrand
Officer |
SELL
Open market or private sale
|
Direct | 70,208 Reduced 86.41% |
$3,211,314
$45.74 p/Share
|
Feb 02
2021 |
|
AMPH
|
Jack Y. Zhang
CEO & CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Indirect | 13,817 Reduced 0.2% |
$257,825
$18.66 p/Share
|
Feb 02
2021 |
|
ADPT
|
Julie Rubinstein
President and COO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 100.0% |
$888,900
$59.26 p/Share
|
Feb 02
2021 |
|
ADPT
|
Harlan S Robins
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 7,790 Reduced 91.98% |
$465,141
$59.71 p/Share
|
Feb 02
2021 |
|
EAT
|
Wade Allen
SVP, Chief Digital Officer |
SELL
Open market or private sale
|
Direct | 630 Reduced 4.24% |
$38,776
$61.55 p/Share
|
Feb 02
2021 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Direct | 11,932 Reduced 78.41% |
$431,103
$36.13 p/Share
|
Feb 02
2021 |
|
MORF
|
Praveen P. Tipirneni
President and CEO |
SELL
Open market or private sale
|
Indirect | 8,000 Reduced 0.43% |
$291,600
$36.45 p/Share
|
Feb 02
2021 |
|
WRLD
|
John L Calmes Jr
Officer |
SELL
Open market or private sale
|
Direct | 11,017 Reduced 22.45% |
$1,464,490
$132.93 p/Share
|
Feb 02
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.71% |
$236,400
$7.88 p/Share
|
Feb 02
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 0.71% |
$236,400
$7.88 p/Share
|
Feb 02
2021 |
|
YEXT
|
Michael Walrath
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 57,418 Reduced 4.36% |
$1,001,944
$17.45 p/Share
|
Feb 02
2021 |
|
BLFS
|
Aby J. Mathew
EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 18,484 Reduced 9.29% |
$743,611
$40.23 p/Share
|
Feb 02
2021 |
|
RLMD
|
Paul Edward Kelly
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 2,315 Reduced 1.41% |
$81,118
$35.04 p/Share
|
Feb 02
2021 |
|
NKTX
|
James Trager
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,800 Reduced 5.61% |
$112,000
$40.0 p/Share
|
Feb 02
2021 |
|
CLVS
|
Paul Edward Gross
Officer |
SELL
Open market or private sale
|
Direct | 11,873 Reduced 21.66% |
$94,628
$7.97 p/Share
|
Feb 02
2021 |
|
CLVS
|
Thomas C. Harding
Officer |
SELL
Open market or private sale
|
Direct | 5,248 Reduced 42.41% |
$41,827
$7.97 p/Share
|
Feb 02
2021 |
|
CLVS
|
Daniel W Muehl
Officer |
SELL
Open market or private sale
|
Direct | 11,872 Reduced 20.17% |
$94,620
$7.97 p/Share
|
Feb 02
2021 |
|
CLVS
|
Lindsey Rolfe
Officer |
SELL
Open market or private sale
|
Direct | 11,813 Reduced 14.67% |
$94,150
$7.97 p/Share
|
Feb 02
2021 |
|
CLVS
|
Gillian C Ivers Read
Officer |
SELL
Open market or private sale
|
Direct | 10,990 Reduced 4.3% |
$87,590
$7.97 p/Share
|
Feb 02
2021 |
|
PHAT
|
Azmi Nabulsi
Chief Operating Officer |
SELL
Open market or private sale
|
Indirect | 9,084 Reduced 0.56% |
$370,900
$40.83 p/Share
|
Feb 02
2021 |
|
ALPN
|
Mitchell Gold
Executive Chairman and CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.33% |
$117,400
$11.74 p/Share
|
Feb 02
2021 |
|
RDI
|
Margaret Cotter
Chairperson, EVP - RE Dev/NY |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$22,120
$5.53 p/Share
|
Feb 02
2021 |
|
RDI
|
James J. Cotter Living Trust
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 0.24% |
$22,120
$5.53 p/Share
|
Feb 02
2021 |
|
RDI
|
Ellen M Cotter
Director, President and CEO |
SELL
Open market or private sale
|
Indirect | 4,000 Reduced 0.24% |
$22,120
$5.53 p/Share
|
Feb 02
2021 |
|
MMNFF
|
Wicklow Capital Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 309,800 Reduced 1.76% |
$65,058
$0.21 p/Share
|
Feb 02
2021 |
|
CRTX
|
Casey Lynch
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.93% |
$727,800
$36.39 p/Share
|
Feb 02
2021 |
|
AXDX
|
Jack Phillips
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 3,313 Reduced 23.97% |
$36,112
$10.9 p/Share
|
Feb 02
2021 |
|
MLSS
|
Giandomenico Trombetta
Director |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.45% |
$130,950
$2.91 p/Share
|
Feb 02
2021 |
|
KOSS
|
Lenore Lillie
VP - Operations |
SELL
Open market or private sale
|
Direct | 35,088 Reduced 100.0% |
$773,340
$22.04 p/Share
|
Feb 02
2021 |
|
KOSS
|
Michael J Koss Jr
VP - Marketing & Product |
SELL
Open market or private sale
|
Direct | 13,948 Reduced 23.27% |
$362,369
$25.98 p/Share
|
Feb 02
2021 |
|
KOSS
|
John C Koss Jr
Vice President - Sales |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 3.81% |
$595,200
$19.84 p/Share
|
Feb 02
2021 |
|
KOSS
|
John C Koss Jr
Vice President - Sales |
SELL
Open market or private sale
|
Direct | 40,133 Reduced 12.49% |
$835,569
$20.82 p/Share
|
Feb 02
2021 |
|
KOSS
|
Michael J Koss
President and CEO |
SELL
Open market or private sale
|
Indirect | 30,000 Reduced 3.81% |
$595,200
$19.84 p/Share
|
Feb 02
2021 |
|
SMED
|
John W Dalton |
SELL
Open market or private sale
|
Direct | 6,400 Reduced 0.73% |
$80,192
$12.53 p/Share
|
Feb 02
2021 |
|
SMED
|
Diana P Diaz
Senior Vice President & CAO |
SELL
Open market or private sale
|
Direct | 63,235 Reduced 88.06% |
$798,658
$12.63 p/Share
|
Feb 02
2021 |